Sansure Biotech Inc (688289) — Tangible Net Worth Ratio
Sansure Biotech Inc (688289) has a Tangible Net Worth Ratio of 91.5% as of March 2026. This metric is calculated by deducting intangible assets (CN¥617.11 Million) from net assets (CN¥7.23 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Sansure Biotech Inc growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sansure Biotech Inc Tangible Net Worth Ratio (2017–2025)
This chart shows how Sansure Biotech Inc's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 91.5%, reflecting net assets of CN¥7.23 Billion with intangible assets of CN¥617.11 Million CNY. For live market cap and overall valuation, see 688289 market cap overview.
Annual Tangible Net Worth Ratio for Sansure Biotech Inc (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Sansure Biotech Inc from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 688289 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.3% | CN¥16.75 Billion | CN¥620.67 Million | CN¥9.53 Billion | ▲ +2.1 pp |
| 2024 | 94.2% | CN¥7.35 Billion | CN¥429.36 Million | CN¥8.60 Billion | ▼ -1.4 pp |
| 2023 | 95.6% | CN¥7.42 Billion | CN¥327.97 Million | CN¥8.45 Billion | ▼ -3.3 pp |
| 2022 | 98.9% | CN¥7.51 Billion | CN¥84.44 Million | CN¥9.17 Billion | ▼ -0.4 pp |
| 2021 | 99.3% | CN¥6.38 Billion | CN¥45.55 Million | CN¥7.09 Billion | ▼ -0.1 pp |
| 2020 | 99.3% | CN¥4.75 Billion | CN¥31.23 Million | CN¥5.45 Billion | ▲ +1.4 pp |
| 2019 | 97.9% | CN¥557.48 Million | CN¥11.49 Million | CN¥642.47 Million | ▲ +0.8 pp |
| 2018 | 97.2% | CN¥396.29 Million | CN¥11.24 Million | CN¥552.04 Million | ▼ 0.0 pp |
| 2017 | 97.2% | CN¥378.99 Million | CN¥10.67 Million | CN¥565.61 Million | — |